Brief: Alphamab Oncology Says Unit & Suzhou Alphamab Enter Technology Development Agreement
31/03/2020 15:12
March 31 (Reuters) - Alphamab Oncology 9966.HK :
* UNIT & SUZHOU ALPHAMAB ENTER TECHNOLOGY DEVELOPMENT
AGREEMENT
FOR OPTIMIZATION & TRANSFER OF PROCESSES FOR 3 DRUG CANDIDATES
OF CO
* UNIT & SUZHOU ALPHAMAB ENTERED TECHNOLOGY DEVELOPMENT
AGREEMENT
FOR PROCESS SCALE-UP RESEARCH OF KN052, A DRUG CANDIDATE OF CO
Source text for Eikon: urn:newsml:reuters.com:*:nHKS9WMZPm
Further company coverage: 9966.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hong Kong Zcloud Technology Construction
See all newsHong Kong ZCloud Technology Construction slips on lower profit forecast
Brief: Hong Kong Zcloud Technology Construction Expects FY Profit Attributable Not Less Than HK$6.5 Mln
Brief: Hong Kong Zcloud Technology Construction Says Wang Daming Redesignated As Executive Director
Brief: Hong Kong Zcloud Technology Construction Appoints Liu Zhiyi As Executive Director
Brief: Hong Kong Zcloud Technology Construction Expects HY Profit Drop To HK$3.2 Million